Advisor Group Holdings, Inc. Evaxion Biotech A/S Call Options Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding EVAX
# of Institutions
1Shares Held
37.5KCall Options Held
0Put Options Held
0About Evaxion Biotech A/S
- Ticker EVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,977,900
- Market Cap $71.2M
- Description
- Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...